Hypoglycemic pharmaceutical can reduce the incidence of prostate cancer

Epidemiological investigations have found that diabetic patients suffering from the relatively low rate of prostate cancer may be taking with the hypoglycemic drugs. Finland Murtola recent research report by a doctor from 1995 to 2002 collected 24,723 cases of diabetes, prostate cancer and did not win first prize is divided into two groups of prostate cancer to compare, the average age is 68 years old, was found taking oral hypoglycemic agents get prostate cancer accounted for 7.5 percent of men have been suffering from prostate cancer using hypoglycemic agents is 8.4%, while the use of insulin to be prostate cancer is 2.5%, control group was 3.0%. According to these statistics, the use of these hypoglycemic agents can reduce 16 percent of prostate cancer from happening, of course, these drugs, including metformin, sulfonylureas or insulin, why take hypoglycemic agents and insulin injections can reduce prostate the incidence of cancer is not yet very clear, because in the past that the risk of diabetes patients with colorectal cancer and so on, but taking hypoglycemic drugs but can reduce the incidence of prostate cancer should be with medication, it is also a need for further study.